Maze Therapeutics, Inc. · NASDAQ:MAZE

Dandekar Atul sold 7,500 Maze Therapeutics, Inc. shares (Form 4)

Traded Mar 30, 2026 · Filed Apr 1, 2026

On Mar 30, 2026, Dandekar Atul (CSBO) sold 7,500 Maze Therapeutics, Inc. shares at an average US$29.34 for US$220K under a trading plan, leaving 10,503 shares. Filed Apr 1, 2026 (Form 4).

Sold
7,500 shares
Price
US$29.34 average (US$29.26 to US$30.02)
Value
US$220K
Holding after
10,503 shares
Trading plan
Yes (Made under a plan set in advance)
Role
CSBO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Mar 30, 2026Common StockOption exercise7,500US$10.4218,003Direct
Mar 30, 2026Common StockSale6,710US$29.2611,293Direct
Mar 30, 2026Common StockSale790US$30.0210,503Direct

Source

View original at SEC

Related